456 Views
Poster Socials are casual, live networking events that allow attendees to video-chat with individual authors in small groups. Attendees are encouraged to table-hop and interact with multiple authors.
M1230-102 A Liquid Chromatography - Mass Spectrometry (LCMS) Approach for Quantitative Assessment of tau Protein Phosphorylation, Li Sun, Merck & Co., Inc. | Table 1
T1230-202 A Model-Based Approach to Evaluating Dose Sensitivity for Comparative PK Studies of Biologics, Shengnan Du, US Food and Drug Administration | Table 3
M1230-105 A Universal Method for the Quantitation of Multiple Oligonucleotides from Plasma by MFLC-MS/MS, Chad D. Christianson, Alturas Analytics, Inc. | Table 5
T1230-206 Accurate Measurement of a Therapeutic Monoclonal Antibody in the Presence of an Interfering Target Molecule in Human Serum, Jin Wang, Amgen | Table 3
R1230-407 Amino Acid-Functionalized Nanodiamonds as Gene Carrier Diamoplexes: Rational Design, Physicochemical Characterization and Biological Interaction Studies, Saniya Alwani, University of Saskatchewan | Table 6
T1230-203 An Investigation of PK Dose-Proportionality for Therapeutic Protein Products, Shengnan Du, US Food and Drug Administration | Table 3
R1230-403 Calculation of Therapeutic Antibody Viscosity with Coarse-Grained Models, Hydrodynamic Calculations and Machine Learning-Based Parameters, Pin-Kuang Lai, Massachusetts Institute of Technology | Table 2
R1230-402 Comparative Performance of Novel Surfactant Excipient and Standard Technologies in Protein Formulations, Hadi Fares, IFF | Table 2
W1230-303 Concentration Determination of Empty and Filled Adeno Associated Virus Capsid Vectors with Multi-angle Dynamic Light Scattering, Ulf Nobbmann, Malvern Panalytical Inc. | Table 3
M1230-106 Development and Pre-validation of a Duplex ddPCR Assay with Statistical Evaluation Using JMP, Stephen Higgins, MS, Smithers PDS | Table 5
M1230-104 Development of a Sensitive and Specific Assay to Measure Serum Anti-CAR Antibodies to an Autologous CAR-Treg Cell Therapy, Khaled Hettini, Sangamo Therapeutics | Table 4
T1230-204 Effect of Subcutaneous Injection Sites on Pharmacokinetics of Monoclonal Antibodies and Fc Fusion Proteins, Shengnan Du, US Food and Drug Administration | Table 3
W1230-301 Low-pH Tolerant Reagents in Combination with the Gyros Microfluidic Platform to Develop Sensitive Pharmacokinetic Immunoassays for Biotherapeutics, Yury Chaly, Bristol-Myers Squibb | Table 1
T1230-207 New Insights into the Metabolism of GalNAc-Conjugated siRNAs, Babak Basiri, Amgen | Table 7
W1230-302 WITHDRAWN BY AUTHOR
R1230-405 Photo-Magnetic Actuator and Actuation Strategy for Novel Nano-Carriers: Treating Cancer Photo-Magnetically? Santaneel Ghosh, Southeast Missouri State University | Table 4